Kymera Therapeutics, Inc. (KYMR) Dividend History
Income profile from 2018 to 2025 with payout safety and yield-on-cost trend
3-Second Income Check
Safety
Payout ratio data not available yet.
Consistency
0 straight years of dividend increases.
Income Trend
Yield on cost trend needs more history.
Dividend Scorecard
Yield & Income
Payout Safety
Growth
Total Returns
Uses precomputed total return metrics from screening data (not lot-by-lot dividend reinvestment transactions). Different time windows can produce different outcomes depending on market regime and entry point.
Dividend History
No dividend payment history available
Dividend Analysis
Payout Safety
Kymera Therapeutics, Inc. has limited earnings payout data (Unknown).
Piotroski F-Score: 4/9 — moderate financial health.
Growth Track Record
KYMR does not have a current streak of consecutive dividend increases.
Total Shareholder Returns
Beyond cash dividends, KYMR returns capital through share repurchases. The combined picture: 0.0% total shareholder yield.
Income Trend & Total Return
The 5-year total return is 88.5%.
DRIP Growth
A $10,000 investment made 10 years ago with dividends reinvested would have grown to approximately $27,466 today.
Dividend Peer Comparison
Peer group: Immunology and Inflammation Therapies
Annual Dividend History
8 years of dividend data
| Year | DPS | YoY | Pmts | EPS | Payout | Coverage | YOC |
|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | — | 0 | $-3.69 | — | — | — |
| 2024 | $0.00 | — | 0 | $-2.98 | — | — | — |
| 2023 | $0.00 | — | 0 | $-2.52 | — | — | — |
| 2022 | $0.00 | — | 0 | $-2.87 | — | — | — |
| 2021 | $0.00 | — | 0 | $-2.09 | — | — | — |
| 2020 | $0.00 | — | 0 | $-0.99 | — | — | — |
| 2019 | $0.00 | — | 0 | $-0.93 | — | — | — |
| 2018 | $0.00 | — | 0 | $-0.48 | — | — | — |
See KYMR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs KYMR Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare KYMR vs AGIO
See how KYMR stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
How much dividend does KYMR pay per share?
Kymera Therapeutics, Inc. (KYMR) pays a trailing 12-month dividend of N/A per share, with a current dividend yield of N/A. Payments are made quarterly.
When is KYMR's next ex-dividend date?
KYMR's most recent ex-dividend date is N/A. You must own shares before the ex-dividend date to receive the next payment. KYMR typically pays dividends quarterly.
Is KYMR's dividend safe?
KYMR's dividend safety is rated "Unknown" based on an earnings payout ratio of N/A and FCF payout ratio of N/A. The dividend history does not yet show a prolonged growth streak.
How many years has KYMR increased its dividend?
KYMR has not maintained a consecutive growth streak recently. The 5-year dividend CAGR is N/A.
How often does KYMR pay dividends?
Kymera Therapeutics, Inc. pays dividends quarterly. The trailing 12-month total is N/A per share. Dividend data on this page covers 7+ years from 2018 to 2025.
How much would $10,000 invested in KYMR grow with dividend reinvestment?
With dividends reinvested (DRIP), $10,000 invested in KYMR five years ago would be worth approximately $18,851 today. This includes both price appreciation and compounded dividend reinvestment. Use the DRIP calculator above for other time periods.
What is KYMR's yield on cost for long-term holders?
KYMR's yield on cost — the current dividend divided by the original purchase price — is N/A for a 5-year holding period. This means long-term holders earn a higher effective yield than today's N/A market yield, thanks to the lower original cost basis.